BlackRock, Inc. 13D and 13G filings for Design Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-09-07 09:38 am Sale |
2023-08-31 | 13G | Design Therapeutics, Inc. DSGN |
BlackRock Inc. BLK |
2,394,544 4.300% |
-1,113,480 (-31.74%) |
Filing |
| 2023-02-03 12:10 pm Purchase |
2022-12-31 | 13G | Design Therapeutics, Inc. DSGN |
BlackRock Inc. BLK |
3,508,024 6.300% |
3,508,024 (New Position) |
Filing |